High-end suppliers of chemical, biological reagents, pharmaceutical intermediates and APIs
Current Location:Home > About Huateng> Honour
More Company Profile  |   Culture  |   Honour  |   R&D Center  |   Contact Us  |  

Honour

In Jun. 2013, Hunan Huateng Pharmaceutical Co., Ltd. was established and established a research and development center in Changsha High-tech Zone;
In Dec. 2013, Huateng Pharmaceutical launched market development, achieved rapid business development, and played an active role in the field of medical research;
In Jan. 2014, the chairman of Huateng Pharmaceutical was successfully selected as a special expert in the 2014 “Hundred Talents Program”;
In Jan. 2014, Huateng Pharmaceutical technical experts were successfully selected into the “555” high-level talent plan project of Changsha High-tech Zone;
In Jun. 2014, Huateng participated in CPhI Shanghai and established cooperative relationships with hundreds of pharmaceutical companies;
In Jul. 2014, Huateng Pharmaceutical was successfully selected as one of the “2014 Most Entrepreneurial Potential Enterprise of China Overseas Students Pioneer Park” (the only selected enterprise in Hunan Province);
In Feb. 2015, Huateng Pharmaceutical participated in the Informex2015 in Orleans, USA;
In Mar. 2015, Huateng Pharmaceutical participated in the ACS' 247th National Meeting & Exposition in Denver, USA;
In Jun. 2015, Huateng Pharmaceutical participated in the CPhI China 2015 in Shanghai, actively promoting the development of Huateng's domestic and international markets;
In Dec. 2015, Huateng Pharmaceutical purchased a new R&D building and established a new R&D center of more than 3,000 square meters.
In Apr. 2016, Huateng Pharmaceutical participated in the CPhI Japan in Tokyo, Japan;
In Jun. 2016, Huateng Pharmaceutical passed the ISO9001;
In Jun. 2016, Huateng Pharmaceutical won the “Changsha Overseas Chinese Chamber of Commerce Executive Director Unit”;
In Jun. 2016, Huateng Pharmaceutical participated in the CPhI Shanghai;
In Nov. 2016, Huateng Pharmaceutical successfully listed the “Hunan Provincial Engineering Research Center”;
In Dec. 2016, Huateng Pharmaceutical successfully won the title of “Innovative Technology Little Giant Enterprise”;
In Dec. 2016, Huateng Pharmaceutical successfully obtained the “National High-Tech Enterprise” certification;
In Dec. 2016, Huateng Pharmaceutical established the “Changsha Academician Expert Workstation”;
In Jun. 2017, Huateng Pharmaceutical successfully won the title of “Changsha Enterprise Technology Center”;
In Jul. 2017, Huateng Pharmaceutical successfully won the title of “Changsha Technology Research Center”;
In Sep. 2017, Huateng Pharmaceutical successfully won the title of “Hunan Little Giant Enterprise”;
In Oct. 2017, Huateng Pharmaceutical successfully won the title of “Key Overseas Chinese Entrepreneurship Team”;
In Nov. 2017, Huateng Pharmaceutical Co., Ltd. won the first prize of the 4th Hunan Innovation and Entrepreneurship Competition;
In Nov. 2017, Huateng Pharmaceutical Co., Ltd. won the Outstanding Enterprise Award of the 6th China Innovation and Entrepreneurship Competition;
In Dec. 2017, Huateng Pharmaceutical successfully won the title of “Haizhi Plan Workstation”;
In Jun. 2018, Huateng Pharmaceutical was approved to establish the “Post-doctoral Research Station Cooperative R&D Center”;
In Aug. 2018, Huateng Pharmaceutical won the “Executive Director Unit of the First Council of Hunan Pharmacology Society”;
In Nov. 2018, Huateng Pharmaceutical officially awarded the “Post-doctoral Research Station R&D Center”.
In Feb. 2019, Huateng Pharmaceutical won the "Advanced Unit for Employment in 2018 Changsha High-tech Zone";
In Mar. 2019, the Huateng Pharmaceutical Industrial Park was laid. The total investment of the project is 300 million yuan and the total construction area is about 34,000 square meters. The project introduces the advanced concept of intelligent manufacturing and uses intelligent manufacturing automation integrated equipment to create world-class production workshop with high efficiency, low cost and low energy consumption;
In Jun. 2019, Huateng Pharmaceutical participated in the CPhI Shanghai;
In Jul. 2019, Huateng Pharmaceutical won the “Top 20 Most Investment-Porthy Project” in the Changsha Division of China 2019;
In Jul. 2019, Huateng Pharmaceutical won the second prize of the China Hunan Small and Medium Enterprises Innovation and Entrepreneurship Competition.
In Sep. 2019, Hunan Huateng Pharmaceutical Co., Ltd. raised 50 million yuan in the series A round of funding led by Tasly Institute.

Up to now, the company has more than 300 national patents, and many products have independent property rights.